A Study of LY3410738 in Healthy Adult Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The main purpose of this study is to assess the safety and tolerability of LY3410738 and to look at the amount of the study drug, LY3410738, that gets into the blood stream and how long it takes the body to get rid of it when given in healthy adult participants. For each participant, the total duration of the study will be 53 days, including screening.
Epistemonikos ID: 987bd564d7666279285c208caa74efcd9ab1ec0d
First added on: May 15, 2024